TBK1 and Parkinson disease: After FMT, neuroinflammation alleviation was observed in PD model mice, characterized by reduced glial activation (including both microglia and astrocytes) and the inhibition of the TLR4/TANK-binding kinase 1 (TBK1)/TNF-α signaling pathway (Sun et al., 2018).